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E F F E C T S O F O B E S I T Y , T O T A L F A S T I N G A N D R E - A L I M E N T A T I O N 
O N L - T H Y R O X I N E ( T 4 ) , 3 , 5 , 3 ' - L - T R I I O D O T H Y R O N I N E ( T 3 ) , 
3 , 3 ' , 5 ' - L - T R I I O D O T H Y R O N I N E ( r T 3 ) , T H Y R O X I N E B I N D I N G 
G L O B U L I N ( T B G ) , C O R T I S O L , T H Y R O T R O P H I N , C O R T I S O L B I N D I N G 
G L O B U L I N ( C B G ) , T R A N S F E R R I N , ^ - H A P T O G L O B I N A N D 
C O M P L E M E N T C'3 I N S E R U M 
By 
Peter C. Scriba1), Manfred Bauer, Dieter Emmert, Ahmed Fateh-Moghadam, 
Gert G. Hof mann, Klaus Horn and C. Renate Pickardt 
A B S T R A C T 
The effects of total fasting for 31 + 10 days followed by re-alimentation 
with an 800 calorie diet on thyroid function, i.e. T 4 , T 3 , r T 3 , R T 3 U (resin 
T 3 uptake), and TSH, and on T B G levels in serum were studied sequent-
ially in obese hospitalized patients (N= 18). Additionally, Cortisol, growth 
hormone, prolactin, parathyrin and free fatty acids were followed as 
hormonal and metabolic parameters, respectively. Further, CBG, trans-
ferrin, ctg-haptoglobin and complement C'3 were measured as represen-
tatives of other serum proteins. 
Results before fasting: T 4 , T 3 , T B G , Cortisol, CBG, a2-haptoglobin and 
complement C'3 of the obese patients were elevated when compared with 
healthy normal weight controls, whereas r T 3 , T 4 / T B G ratio, T 3 / T B G ratio, 
TSH, cortisol/CBG ratio, growth hormone, prolactin, parathyrin and 
transferrin of the obese group were normal. R T 3 U and f T 4 index were 
decreased in the obese patients. 
Results during fasting: Significant decreases were observed during fasting 
for the following parameters - T g , T B G , Tg/TBG ratio, transferrin, a 2 -
0 A preliminary report was presented at the X L Acta Endocrinologica Congress, 
Lausanne, Switzerland (Scriba et al. 1977). 
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haptoglobin, complement C'3. r T 3 , T 4 / T B G ratio, R T 3 U , f T 4 index and 
F F A increased. T 4 , T S H response to T R H stimulation, Cortisol, CBG, 
cortisol/CBG ratio, parathyrin, growth hormone and prolactin did not 
change. 
Results during re-alimentation: T g , T B G , Tg/TBG ratio, T S H response 
to T R H , transferrin, a2-haptoglobin and complement C'3 increased. Con-
versely, r T 3 , R T 3 U , F F A , Cortisol and cortisol/CBG ratio decreased, 
whereas the other parameters did not change. 
Conclusions: 1) There is no evidence for primary hypothyroidism in obese 
patients during prolonged fasting and re-alimentation. 2) The rapid de-
crease of T 3 and increase of R T 3 U after initiation of fasting are not fully 
explained by the observed slower decreases in T B G . 3) The alterations of 
T 3 , r T 3 and R T 3 U resemble in their kinetics the changes in F F A levels. 
4) Fasting reduced the levels of only certain serum proteins, interestingly 
T B G , transferrin, a2-haptoglobin and complement C'3, all of which, except 
transferrin, are elevated in obesity. 5) The magnitude of the observed de-
creases does not suggest any clinically relevant deficiencies in serum pro-
teins. 6) Re-alimentation reverses rapidly all observed changes. 
Several recent publications have dealt with alterations of thyroid hormone 
metabolism in obese patients during total fasting. 3,5,3'-L-triiodothyronine ( T 3 ) 
levels in serum were shown to decrease during fasting whereas the meta-
bolically inactive metabolite of thyroxine 3,3',5'-L-triiodothyronine (reverse 
T 3 , r T 3 ) increased (Balsam 8c Ingbar 1977; Carlson et al. 1977; Cr ox son et al. 
1977; Merimee 8c Fineberg 1976; Palmblad et al. 1977; Portnay et al. 1974; 
Vagenakis et al. 1975, 1977) while total thyroxine ( T 4 ) levels remained constant. 
The daily weight loss decreased during several weeks of total fasting and the 
basal metabolic rate (BMR) also diminished with the duration of the fasting 
(Ditschuneit 1976). This study was performed in order to evaluate the 
possibility that the changes in B M R could be due to thyroid hormone deficiency 
arising from fasting (Hofmann et al. 1974; Scriba et al. 1967; Scriba 8c Hof-
mann 1976). 
The total thyroid hormone concentration in serum depends on the con-
centration of their specific transport proteins of which thyroxine binding 
globulin ( T B G ) is the most important. For this study, it had to be taken into 
consideration that the serum globulins transferrin, a2-haptoglobin and comple-
ment C'3 (/^A-globulin) decreased during total fasting of 3 weeks duration 
(Fateh-Moghadam et al. 1977). The alterations of the T B G levels during fasting 
and re-alimentation had therefore to be studied for a better understanding 
of the thyroid function of obese patients during this procedure, also in view of 
the fact that an abnormally high binding of thyroid hormones to serum proteins 
has been reported in earlier studies (Premachandra et al. 1970; Schatz et al. 
1967; Scriba et al. 1967). 
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M E T H O D S 
Patients 
Treatment of alimentary obesity by total fasting of maximally 50 days duration was 
performed on 18 hospitalized patients, in whom other metabolic or endocrine diseases 
and liver or kidney diseases, respectively, had been excluded. The patients received an 
800 calorie (3336 kj) mixed diet for subsequent re-alimentation. Patients admitted to 
this study had no recent treatment with metabolically active drugs, in particular 
laxatives, diuretics, thyroid hormones or corticosteroids. In the female patients, no 
hormonal contraception had been practised for at least 4 weeks prior to the initiation 
of the fasting. The mean age of the patients was 27 years, 9 males were from 15 to 39 
years old, 9 females from 16 to 46 years. The mean initial weight was 168.5 ± 20.5% 
(SD) of the ideal weight in females and 166.4 ± 20.2 <Vo in males. 
Fasting 
The mean duration of the fasting was 31 ± 10 days, the daily weight loss was 
454 ± 96 g/day in females and 547 ± 137 g/day in males. The following determinations 
were performed for control of the fasting and as a precaution against complications: 
Free fatty acids, calcium, potassium, sodium and uric acid in serum, acetone in urine 
and electrocardiogram at least weekly. The transaminases were controlled fortnightly. 
A minimal calorie-free fluid input of 2 1/day was maintained. A polyvitamin prepara-
tion lacking vitamin D was given daily, potassium was administered whenever there 
was a tendency for lowering of serum potassium. Allopurinol (300 mg/day) which is 
known to leave iodine metabolism unchanged (Rosenkrantz et al. 1968), was ad-
ministered orally, whenever the uric acid level rose above 12 mg/100 ml. Some patients 
received colloidal aluminium phosphate. Blood samples were drawn between 8 and 9 
a.m. at intervals indicated in Figs. 1 and 2, and before breakfast during the re-alimen-
tation period. 
Laboratory methods 
Triiodothyronine, T 3 {Horn et al. 1975), reverse triiodothyronine, r T 3 (Meinhold et 
al. 1975), thyroxine binding globulin, T B G {Horn et al. 1977), thyrotrophin {Erhardt 
et al. 1973), Cortisol {Horn et al. 1975), corticosteroid binding globulin, CBG {Bernutz 
et al. 1978), parathyrin, P T H {Wood et al. 1978), growth hormone and prolactin {von 
Werder 1975) were determined by published radioimmunoassay (RIA) procedures. 
Thyroxine determinations, using competitive protein binding assay (CPBA), and Tg-
uptake tests, T 3 U , were performed as published {Horn et al. 1975). Transferrin, a2-
haptoglobin and complement C'3 were determined by radial immunodiffusion after 
Mancini et al. (1965) and Lamerz et al. (1973). Free fatty acids, FFA, were analysed 
by a modification {Dieterle et al. 1968) of the colorimetric assay (Duncombe 1963). 
Statistical evaluation 
Student's Mest was used for the comparison of pre-fasting levels of obese patients 
and of controls. Student's non-paired Mest may however not be used for the evaluation 
of sequential changes when more than two sampling times are involved. The sequential 
data during total fasting and re-alimentation are certainly not independent. Therefore, 
the regression of the measured values against the time and also the linearity (one way 
analysis of variance) were calculated {Sachs 1972). The significance of observed 
alterations could then be calculated from the correlation coefficient r and from the 
number of determinations N. Both, the fasting and the re-alimentation were separated 
into two periods in order to allow for better description of the kinetics of the observed 
alterations: Fasting periods I (day 1-15) and II (day 15-end); re-alimentation periods 
I (day 1-6) and II (day 6-30). 
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Fig, 1. 
Triiodothyronine (T 3 -RIA) , rT 3 , thyroxine binding globulin, T3/TBG ratio, and free 
fatty acids before and during fasting and re-alimentation of obese patients. 
Superimposed normal means ± 2 standard deviations of all measured parameters 
correspond to the following data: 
T3-RIA: 116 ± 3 6 ng/100 ml; r T 3 
T./TBG: 58 ±36 . 
0.207 ±0.184 ng/mJ; TBG: 2.0 ± 0.8 ml/100 ml: 
FFA: 480 ± 250 //Eq./l. 
R E S U L T S 
Triiodothyronine (T:i) 
The in i t ia l T 3 levels of the obese patients ( N = 1 8 ) of 141 ± 21 ng/100 ml 
(mean ± SD) were wi th in the normal range but significantly (P < 0.001) above 
the mean (Horn 1976) of healthy normal weight controls (N = 58) of 1 1 6 ± 18 
ng/100 m l (Horn 1976). A rapid decline of the T 3 levels was observed during 
the first 2 weeks of total fasting (Fig. 1, Table 1). The decrease was linear and 
significant (r = - 0.6379; P < 0.001, N = 58). A linear increase was observed 
during the second fasting period, i.e. after the 15th day (r = + 0.3781; P < 0.001, 
N = 50). A further increase of the T 3 levels was observed dur ing the re-alimen-
tation period, which was linear and significant during the first re-alimentation 
period (r = + 0.2579; P < 0.05, N = 62) and non-linear but significant after the 
6th day of re-alimentation (r = + 0.4138: P < 0.05, n = 27). 
Reverse T3 (rT3) 
The sequential r T 3 levels were determined in only 5 patients. The in i t ia l 
r T 3 level of these patients of 0.22 ± 0.06 ng/ml (mean ± SD) was wi th in the 
632 
Table 1. 
Changes in the serum levels of triiodothyronine (T.j), (rT. {), thyroxine (Tj), thyroxine binding globulin (TBG), T^/TBG ratio, T.^TBG ratio, 
T3-uptake, free thyroxine index, free fatty acids and basal thyrotrophin, respectively TSH increase 30 min after 200 fig TRH iv, before 
and during fasting and re-alimentation of obese patients (mean ± SD) . 
Total fasting Re-alimentation 
before 7.- 15. day 25.-30.day before 5.-6. day 15.-30.day 
T.J ng/100 ml 141 ± 2 1 7 7 ± 14 86 ± 18 89 ± 24 107 ± 22 144 ± 36 
rT.j ng/ml 0.22 ± 0.06 0.38 ± 0 .15 0.27 ± 0 .10 0.24 ± 0.03 0 .18 ± 0.02 0.20 ± 0.04 
T 4 / / g / 1 0 0 ml 8.3 ± 2.4 8.1 ± 2.3 7.2 ± 1.7 7.4 ± 1.5 7.4 ± 1.2 8.1 ± 2 . 1 
TBGmg/lOOml 2.6 ± 0.5 2.2 ± 0.3 1.9 ± 0 . 2 2.0 ± 0.2 1.9 ± 0.3 2.4 ± 0 . 6 
Tj/TBG 
T. /TBG 
3.20 ± 0.94 3.7 6 ± 1.09 3.70 ± 0.90 3.78 ± 0.9 3.86 ± 0.93 3.72 ± 1.18 
58.1 ± 17.8 35. 8 ± 6.0 45.0 ± 10.2 46,2 ± 12.4 55.3 ± 12.9 60.7 ± 15.0 
RT.jU °/o 31.3 ± 4.6 37. 8 ± 5.0 38.7 ± 4.8 38.1 ± 5.9 36.2 ± 6.5 33.8 ± 7.0 
f T , - I 2.56 ± 0.66 3.04 ± 0.91 2.86 ± 0.64 2.80 ± 0.67 2.65 ± 0.57 2.64 ± 0.73 
FFA //Eq./l 591 ± 108 1395 ± 5 1 4 1594 ± 636 1288 ± 530 832 ± 327 688 ± 207 
TSH basal aU/m\ 1.3 ± 0 . 7 1.4 ± 0 . 5 1.4 ± 0 . 5 
A T S H 3 ( ) m i i ; , U / m l 6.8 ± 3.9 5.6 ± 2.1 9.1 ± 4 . 7 
normal range of 0.023-0.391 ng/ml . A significant increase of this metabolite 
(Fig. 1, Table 1) was observed dur ing the first fasting period (r = + 0.5683; 
P < 0.05, N = 14). A mir ror image decline in r T ; } levels was seen dur ing the 
second fasting period when compared w i t h the T 3 levels. A further significant 
decrease of rT ; 3 was observed dur ing the first re-alimentation period (r = 
-0.5955; P < 0.01, N = 20). 
Thyroxine (T4) 
The in i t i a l T , levels (Table 1) in obese patients of 8.3 ± 2.4 //g/100 ml were 
significantly higher than the mean value of age-matched normal weight controls 
(Horn 1976; Horn et al. 1977) of 6.7 ± 1.3 //g/100 m l {P < 0.01). There were 
no significant changes of the T 4 levels neither during fasting nor during re-
alimentation. 
Thyroxine binding globulin (TBG) 
The in i t i a l T B G levels (Fig. 1, Table 1) of obese patients of 2.6 ± 0.6 mg/ 
100 ml were significantly higher than the mean of age-matched normal weight 
controls of 2.0 ± 0.4 mg/100 m l (P < 0.001). The T B G levels decreased signi-
ficantly and l inearly (r = - 0.3957; P < 0.001, N = 56) dur ing the first fasting-
period. No further change of the T B G level was observed dur ing the second 
fasting period. However, a significant increase of the mean T B G level was 
observed during the re-alimentation period (r = + 0.3049; P < 0.01, N = 80). 
T/TBG ratio 
Before the fasting, the mean T , / T B G ratio of obese patients of 3.20 ± 0.94 
(//g/mg; equivalent to a molar ratio of 0.249) was practically identical w i th 
the mean of age-matched normal weight controls (Horn et al. 1977) of 3.17 ± 
0.88. A significant and linear increase of the T 4 / T B G ratio (r = + 0.2567; 
/ > < 0 . 0 1 , N = 102) was observed dur ing the complete fasting period, whereas 
the T j / T B G ratio remained elevated dur ing re-alimentation. 
TJTBG ratio 
The Tg /TBG ratio decreased from an in i t i a l value of 58 ± 18 (ng/mg, which 
is equivalent to a molar ratio of 0.021) significantly and l inear ly to 36 ± 6 
(r = - 0.4904; P < 0.001, N - 56) during the first fasting period (Fig. 1, Table 
1). Dur ing the second fasting period, however, the T 3 / T B G ratio rose already 
significantly and l inearly (r = + 0.3429; P < 0.05, N = 50). There was a further 
significant but non-linear increase of the T 3 / T B G ratio dur ing re-alimentation 
(r = - 0.3860; P < 0.001, N = 74). 
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Fig. 2. 
T i ?-uptake (RT.^U), thyroxine binding globulin, thyroxine, free fatty acids, and free 
thyroxine index before and during fasting and re-alimentation of obese patients. 
Superimposed normal means + 2 standard deviations of all measured parameters 
correspond to the following data: 
R T 3 U : 37 ± 5 °/o; TBG: 2.0 ± 0.8 mg/100 ml; T 4 : 6.7 ± 2.6 wg/100 ml; FFA: 480 ± 250 
//Eq./l, fT 4-index: 2.9 ± 0.9. 
T^-uptake test (RT3U = resin T:j uptake) 
The T 3 -uptake of the obese patients (Fig. 2, Table 1) of 31.3 ± 4.6 °/o was 
in i t i a l l y just below the normal range of 32-42 % (Horn et al. 1975) and thus 
significantly lower (Scriba el al. 1967) than in healthy normal weight controls 
(P < 0.001). There was a significant and linear increase of the T 3 -uptake 
(r = + 0.4202; P < 0.01, N = 55) during the first 15 days of fasting. The decrease 
of the T 3 -uptake during re-alimentation was again linear and significant 
(r = - 0 . 3 0 2 1 ; P < 0.001, N = 80). 
Free thyroxine index (fT4-index) 
The fTj - index ( T 4 x R T 3 U ) was in i t i a l l y 2.56 + 0.66 in the obese patients 
and thus significantly lower than i n healthy normal weight controls (Fig. 2, 
Table 1). A slight increment to 3.04 ± 0.91 was observed dur ing the first fasting 
period (r = + 0.2346; P < 0.05, N = 55) w i t h a subsequent decrease toward the 
in i t i a l value. 
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Table 2. 
Changes in serum levels of the glycoproteins corticosteroid binding globulin, transferrin, a.>-haptoglobin and complement C'3 (ß^A-
globulin), of Cortisol and of the cortisol/CBG ratio before and during fasting and re-alimentation of obese patients (mean ± SD) . 
Total fasting Re-aliinentalion 
before 7.-15. day 25.-30. day before 5.-6. day 15.-30. day 
CBG mg/100 ml 4.0 ± 1.1 4.1 ± 1.4 3.7 ± 0.9 3.5 ± 0.8 3.9 ± 1.5 3.5 ± 1.0 
Cortisol /./.g/100 ml 19.0 ± 9.4 19.5 ± 9.5 18.0 ± 10.8 19.7 ± 9.8 17.9 ± 8.1 11.8 ± 4.5 
Cortisol/CBG ratio 5.13 ± 2.79 5.95 ± 4.68 5.46 ± 4.00 5.83 ± 3.10 5.17 ± 2.19 3.41 ± 1.11 
Transferrin mg/100 ml 293 ± 47 238 ± 67 221 ± 39 212 ± 39 219 ± 41 249 ± 46 
rt.j-haptoglobin mg/100 ml 250 ± 138 131 ± 55 126 ± 69 155 ± 90 178 ± 1 1 1 228 ± 156 
Complement C'3 mg/100 ml 131 ± 14 101 ± 24 97 ± 37 100 ± 32 104 ± 38 109 ± 27 
TSH levels before and after TRH stimulation tests 
The mean basal T S H levels of the obese patients (Table 1) and the T S H 
increments observed after T R H stimulation were w i t h i n the normal range. 
Both values, however, measured in 16 patients before the in i t ia t ion of the 
fasting, were significantly lower (P < 0.0025) than in healthy normal weight 
controls (Erhardt et al 1973). The T S H increment of 5.6 ± 2.1 / / U / m l . 
measured in the obese patients after 2 weeks of fasting, was not significantly 
lower than the in i t i a l value. However, the T S H increment after 2 weeks of 
re-alimentation (Table 1) was significantly higher (P < 0.005) than during 
fasting. 
Free fatty acids (FFA) 
The free fatty acids (Fig. 1, Table 1) were elevated throughout the complete 
fasting period. A sharp linear and significant F F A increase was observed 
during the first fasting period (r = + 0.6933; P < 0.001, N = 54). A linear and 
significant decrease of the F F A was observed during the first 6 days of re-
alimentation (r = - 0.3545; P < 0.01, N = 61). 
Cortisol 
The obese patients had Cortisol levels of 19.0 ± 9.4 //g/100 ml (Table 2). The 
mean Cortisol level of the obese patients was found at the upper l imi t of the 
normal range (Horn et al. 1975) and was significantly higher than the mean 
of healthy normal weight controls of 11.1 ± 3.7 //g/100 ml (P < 0.01). Cortisol 
levels remained constant during fasting but a significant decrease to 11.8 ± 4.5 
//g/100 m l was seen during re-alimentation (r = - 0.2450; P < 0.05, N = 7 7 ) . 
Corlicosleroid-binding globulin (CBG) 
The mean CBG levels of the obese patients (Table 2) were in i t i a l ly 4.0 ± 1 . 1 
mg/100 ml ( N = 18) and thus significantly (P < 0.005) higher than the mean 
of age-matched normal weight controls of 3.4 ± 0.5 mg/100 ml ( N = 40). The 
CBG levels remained constant dur ing the first fasting period and showed a 
non-significant decline during the second fasting period (r = - 0.2404; P < 0.1, 
N = 50). Likewise, there were no significant alterations of the CBG levels 
during re-alimentation. 
Cortisol/CBG ratio 
The cortisol/CBG ratio of the obese patients was in i t i a l l y 5.13 ± 2 . 7 9 and 
remained constant dur ing the complete fasting period (Table 2). A decrease 
was observed at the end of the re-alimentation period which paralleled the 
decline of the Cortisol levels (r = - 0.2628; P < 0.005, N = 76). 
Transferrin 
The in i t i a l transferrin levels of the obese patients of 293 ± 47 mg/100 m l 
were not significantly different from the mean normal weight controls (Fateh-
Moghadam et al 1977) of 295 ± 95 mg/100 ml (Table 2). A significant and 
linear decrease was observed dur ing the complete fasting period (r = -0 .6270 ; 
P < 0.001, N = 98) w i t h a min imum af 212 ± 3 5 mg/100 m l . The transferrin 
levels rose dur ing re-alimentation l inearly and significantly to 249 ± 46 mg/ 
100 ml (r = + 0.3655; P < 0.001, N = 78). 
ao-haptoglobin 
The a 2 -haptoglobin levels of obese patients were in i t i a l l y 250 ± 138 mg/100 
ml and thus above the normal range of 25-220 mg/100 m l (Fateh-Moghadam 
el al. 1977). The ^-haptoglobin levels decreased l inearly and significantly 
during the first fasting period (Table 2) to a min imum af 126 ± 69 mg/100 m l 
(r = - 0 . 3 3 4 1 ; P < 0.05, N = 51). A n increase was already observed dur ing the 
second fasting period (r = + 0.3375; P < 0.005, N = 50) followed by a further 
linear and significant increase during the re-alimentation period (r = + 0.3162; 
P < 0.01, N = 78). 
Complement C'3 (ß}A-globulin) 
The in i t i a l complement C'3 levels of the obese patients (131 ± 13.6 mg/100 
ml) were higher as compared to normal weight controls (108 ± 15 mg/100 ml) 
(Fateh-Moghadam et al. 1977). There was a significant decrease (Table 2) 
during fasting (r = - 0.3489; P < 0.001, N = 98), whereas dur ing subsequent 
re-alimentation, the complement C'3 levels rose l inearly, but not significantly, 
to 109 ± 27 mg/100 ml (r = + 0.1978; P < 0 . 1 , N = 78). The complement C'3 
level did not reach the in i t i a l value during the observation period, however, the 
mean of normal weight controls was reached. 
Parathyrin (PTE) 
The in i t i a l mean P T H levels of obese patients were w i t h 0.35 ± 0.31 ng/100 
m i w i t h i n the normal range of 0.2-1.0 ng/ml (Wood el al. 1978). No signi-
ficant alterations were observed during fasting and re-alimentation. However, 
47 of a total of 164 sera obtained for P T H determination showed a P T H level 
below the l i m i t of detection of 0.2 ng/ml (28.6 % ) . The correct calcium balance 
could not be calculated in this study, but the calcium intake, chiefly through 
mineral water, was estimated to be 200-300 mg/day. 
Growth hormone and prolactin 
No significant alterations of the growth hormone and prolactin levels were 
observed during fasting and dur ing re-alimentation, either i n male or in female 
patients. 
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D I S C U S S I O N 
Obese patients before fasting 
Early observations (Scriba et al. 1967) have shown that the protein bound 
iodine (PB 1 - 7 ! ) and part icularly the T 3 -uptake were significantly lower in 
obese patients than in normal weight controls, although the mean values of 
both were w i t h i n the normal ranges. The possibility of a tendency towards 
thyroid hormone deficiency in obesity was discussed on the basis of these 
studies. However, the direct determination of T 3 and T 4 , and of T S H levels 
before and after T R H stimulation, showed that patients w i t h alimentary obesity 
have higher mean T 3 levels than normal weight controls (Bray el al. 1976; 
Hof mann et al. 1974), and that the T S H levels before and after T R H stimula-
t ion are not elevated. I t was concluded from the latter studies, that obese 
patients are euthyroid and that at least pr imary hypothyroidism can be excluded 
for this condition. 
This study shows that the mean values of T 4 , T 3 and T B G in obese patients 
are elevated but w i t h i n the normal range (Figs. 1 and 2) as compared wi th 
normal weight controls. The normal T 4 / T B G ratio and the normal T S H levels 
of these patients (Table 1) speak against any pr imary hypothyroidism i n these 
patients. 
Some serum proteins are known to be elevated in non-fasted obese patients, 
e.g. albumin and pseudoCholinesterase (Fateh-Moghadam et al. 1977). I n 
accordance w i t h earlier observations (Fateh-Moghadam et al. 1977), the patients 
of this study were found to have elevated mean values for « 2 " h a p t x ) g l 0 D m and 
complement C'3. Moreover, this is the first demonstration of elevated T B G and 
C B G levels by direct measurement. Noth ing appears to be known about the 
regulation of the different serum proteins in hyperalimentation of different 
dietary composition. 
Effects of total fasting 
The study confirms the rapid decline of T 3 and the mir ror image increase of 
r T 3 dur ing fasting, as published by other investigators (Balsam Sc Ingbar 1977; 
Carlson et al. 1977; Croxson et al. 1977; Merimee Sc Fineberg 1976; Palmblad 
et al. 1977; Portnay et al. 1974; Vagenakis et al. 1975, 1977). This "shift" of 
the peripheral monodeiodination of T 4 from the metabolically active t r i iodo-
thyronine to the inactive r T 3 can be interpreted as adaptation of metabolism to 
the reduction of energy provision from calorie-intake. The mechanism of this 
alteration of the hormone metabolism remains unknown (Balsam 8c Ingbar 
1977; Chopra 1978; Palmblad et al. 1977). The obvious kinetic parallelism of 
the increases of the F F A and rT^ levels and their inverse relation to T 3 raise 
the question of the regulatory effect of F F A on the monodeiodination of T 4 . 
I t should be noted in addition, that recently a decrease of the hepatic T 3 re-
ceptor binding capacity during fasting was shown (Schussler Sc Orlando 1978). 
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The thyroxine levels of obese patients remained constant dur ing total fasting 
in accordance wi th the literature. (Merimee Sc Fineberg 1976; Palmblad et al. 
1977; Portnay et al. 1974). Here, the long half - l i fe of T 4 has to be taken into 
consideration. 
A decrease of thyroxine binding capacity (Schatz el al. 1967) was observed 
in serum of fasting obese patients, and low T B G levels were reported in 
protein calorie malnutr i t ion (Rastogi el al. 1974; Chopra 8c Smith 1975). This 
study has shown, by direct radioimmunoassay (Horn el al. 1977), that the T B G 
levels decrease dur ing the first 2 weeks of total fasting. Interestingly similar 
kinetics were observed for the decrease of complement C'3, a 2 -haptoglobin and 
transferrin during fasting. Corticosteroid binding globulin and likewise albumin 
(Fateh-Moghadam et cd. 1977), however, remained constant throughout the 
complete fasting period. I t remains an open problem, as to why only certain 
serum proteins decrease rapidly during total fasting. This decrease appears to 
include mainly those serum proteins, which are elevated in obese patients be-
fore fasting when compared w i t h normal weight controls. As the mean of the 
serum proteins does not fa l l essentially below the respective normal values 
wi th the duration of total fasting applied in this study, i t appears unlikely that 
the patients are in any danger, for example of becoming deficient in immuno-
globulins. 
The decrease of the specific transport globulins of thyroid hormones explains 
only par t ia l ly the known increment in T 3 -uptake (Schatz et al. 1967; Scriba Sc 
Hof mann 1976) and decrease of total T 3 . Comparing the kinetics of the T B G 
decrease and of the increase of T 3 -uptake (Fig. 2) i t can be seen that the i n -
crement of T 3 -uptake is more rapid. The displacement of thyroid hormones 
from T B G by the FFA increase has been suggested (Hollander el al. 1967) as 
one explanation for the phenomenon. Further, total T$ decreases more rapidly 
and intensively than T B G (Fig. 1), explaining the depression of the T 3 / T B G 
ratio during the first fasting period. The T3 /TBG ratio increases already dur ing 
the second fasting period in parallel to the T 3 levels. These results show that 
the most evident metabolic alterations occur w i t h i n the first 2 weeks of total 
fasting. 
A n increase of the T 4 / T B G ratio was observed in obese patients after 2 weeks 
of total fasting in contrast to the decrease of the T 3 / T B G ratio when compared 
w i t h the in i t i a l values. This leads to the important question as to whether obese 
patients are indeed euthyroid throughout the complete fasting period, pa r t i -
cularly w i t h respect to the known decrease of dai ly weight loss w i t h longer 
duration of the fasting (Dilschnneit 1976). I f one accepts the T S H response 
to T R H stimulation as the most sensitive parameter for the thyro id hormone 
status of a patient, the results of this study exclude any pr imary hypothyroidism. 
I n accordance wi th other investigators (Carlson el al. 1977; Croxson el cd. 
1977; Palmblad el cd. 1977; Portnay et cd. 1974; Vinik el al. 1975), no i n -
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creased T S H response was observed but rather a tendency to a sl ightly de-
creased T S H increment after T R H stimulation during fasting. The possibility 
should be kept in mind, that these T S H levels are inadequately low. Con-
versely, one should realise the possibility of an alteration of hypothalamic or 
pi tui tary functions during total fasting (Carlson et al. 1977). Secondary endo-
crine disturbancies of this type have been repeatedly documented for patients 
wi th anorexia nervosa (Travaglim et al 1976; Vigersky el al 1976); thus some 
degree of thyroid hormone deficiency due to hypothalamic dysfunction cannot 
be excluded w i t h certainty on the basis of current data. The latter possibility 
could serve as a vague rational basis for the acceleration of the weight loss 
of fasting obese patients, when, for example, 60 ug T 8 per day are given 
addit ionally (Hof mann el al 1974; Scriba 8c Hof mann 1976). 
Re-alimentation 
A rapid normalisation of the free fatty acids was observed dur ing re-alimenta-
tion w i t h a low caloric diet, representing a normalisation of the stimulated 
lipolysis. T 8 levels were normalised w i t h i n the first days of re-alimentation 
and reached the in i t i a l ly elevated mean values of obese patients dur ing the 
second period of re-alimentation. Recently it was shown that glucose given 
oral ly but not intravenously normalises T j levels after 48 h fasting (Westgren 
et al. 1977). Obviously, the peripheral thyroid hormone metabolism was 
rapidly normalised during re-alimentation. 
The increase of the T B G levels was somewhat slower, resulting in an st i l l 
elevated T. }/TBCr ratio at the end of the observed period of re-alimentation. 
The T j / T B G ratio was increased during the complete re-alimentation period 
when compared wi th the in i t ia l value. Inspite of this, the T S H response to T R H 
stimulation was higher at the end of the re-alimentation than during fasting 
(Table 1). The increasing T B G levels probably bind more T , , which can be 
supplied by the thyroid only at the cost of increased thyrotrophic stimulation. 
Transferr in, ^ -haptoglobin and complement C'3 increase dur ing re-alimenta-
tion. None of these serum proteins, however, reached the in i t i a l l y elevated 
levels observed in obese patients un t i l the end of (he observed period of 
re-alimentation. This f inding shows that there is no persisting deficiency of 
serum proteins after total fasting. 
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